0
Xenetic Biosciences, Inc. Banner Image

Xenetic Biosciences, Inc. has reached its limit for free report views

Work for Xenetic Biosciences, Inc.? Upgrade Your Profile and unlock all your annual reports.

Xenetic Biosciences, Inc.

  • Ticker XBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Xenetic Biosciences, Inc. Logo Image
  • 1-10 Employees
  • Based in Framingham, Massachusetts
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCARTâ„¢, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomasMore. XCARTâ„¢ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
Xenetic Biosciences, Inc.

Most Recent Annual Report

Xenetic Biosciences, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Xenetic Biosciences, Inc. has reached its limit for free report views.

Older/Archived Annual Reports